Korro Bio, Inc. KRRO
NASDAQ · United States · Health Technology
$9.73+0.01 (+0.15%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -1.07 | -1.34 | +20.0% | $0 | -100.0% | +15.2%$11.50→$13.25 |
| Q1 2026 | 2026-05-07 | -1.69 | -1.60 | -5.6% | — | — | -9.7%$13.34→$12.05 |
| Q4 2025 | 2026-03-12 | -1.65 | -2.14 | +22.9% | — | — | +8.8%$11.76→$12.80 |
| Q3 2025 | 2025-11-12 | -1.92 | -2.61 | +26.4% | — | — | -80.2%$32.80→$6.50 |
| Q2 2025 | 2025-08-12 | -2.74 | -2.59 | -5.8% | — | — | — |
| Q4 2024 | 2025-03-18 | -2.26 | -2.51 | +10.0% | — | — | — |
| Q2 2024 | 2024-08-13 | -2.43 | -2.43 | 0.0% | — | — | — |
| Q1 2024 | 2024-05-14 | -2.44 | -2.49 | +2.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.